Abstract
Cystic echinococcosis (CE) is a serious helminthic zoonosis caused by Echinococcus granulosus metacestode worldwide. The current chemotherapy of CE is mainly based on albendazole (ABZ). However, more than 20% CE cases failed to such chemotherapy. Thus, novel and more efficient treatment options are urgently needed. This study was to evaluate the in vivo efficacy of combined ABZ-interferon (IFN)-α treatment for CE in mice. After 5 months of secondary infection with protoscoleces, mice were randomly allocated into four groups: ABZ-treated group, IFN-α-treated group, ABZ+IFN-α group, and untreated control group. Drugs in diverse treated groups were respectively administered for 2 months. Mice were then euthanized and associated indications were investigated to evaluate the therapeutic efficacy. ABZ+IFN-α induced a significant reduction of the number, size, as well as weight of cysts, compared with that in the ABZ (p < 0.05) or untreated group (p < 0.01), respectively. This effect was associated with ultrastructural modification of the cyst in the ABZ+IFN-α group. Interestingly, significant decrease of IL (interleukin)-10 in serum and in vitro production by spleen cells with ABZ+IFN-α treatment was observed in comparison with untreated control (p < 0.01). Serum IgE, IgG, and subsets were respectively decreased in ABZ+IFN-α treatment, compared with that in the control group (p < 0.01). In conclusion, our findings demonstrated that combination of ABZ with IFN-α may contribute to an efficient therapeutic regimen of human and animal CE.
Similar content being viewed by others
References
Ahmadnia S, Moazeni M, Mohammadi-Samani S, Oryan A (2013) In vivo evaluation of the efficacy of albendazole sulfoxide and albendazole sulfoxide loaded solid lipid nanoparticles against hydatid cyst. Exp Parasitol 135(2):314–319. doi:10.1016/j.exppara.2013.07.017
Amri M, Mezioug D, Touil-Boukoffa C (2009) Involvement of IL-10 and IL-4 in evasion strategies of Echinococcus granulosus to host immune response. Eur Cytokine Netw 20(2):63–68. doi:10.1684/ecn.2009.0154
Arico E, Belardelli F (2012) Interferon-alpha as antiviral and antitumor vaccine adjuvants: mechanisms of action and response signature. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 32(6):235–247. doi:10.1089/jir.2011.0077
Breijo M, Isnardi F, Brauer M, Schenker R, Ferrari M, Ferreira AM (2011) An insect growth inhibitor—lufenuron—enhances albendazole activity against hydatid cyst. Vet Parasitol 181(2–4):341–344. doi:10.1016/j.vetpar.2011.04.011
Brunetti E, Kern P, Vuitton DA, Writing Panel for the W-I (2010) Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop 114(1):1–16. doi:10.1016/j.actatropica.2009.11.001
Ceballos L et al (2008) Albendazole treatment in cystic echinococcosis: pharmacokinetics and clinical efficacy of two different aqueous formulations. Parasitol Res 103(2):355–362. doi:10.1007/s00436-008-0980-x
Elissondo M et al (2006) In vitro effects of flubendazole on Echinococcus granulosus protoscoleces. Parasitol Res 98(4):317–323. doi:10.1007/s00436-005-0026-6
Falagas ME, Bliziotis IA (2007) Albendazole for the treatment of human echinococcosis: a review of comparative clinical trials. The American journal of the medical sciences 334(3):171–179. doi:10.1097/MAJ.0b013e31814252f8
Gavidia CM et al (2010) Evaluation of oxfendazole, praziquantel and albendazole against cystic echinococcosis: a randomized clinical trial in naturally infected sheep. PLoS Negl Trop Dis 4(2):e616. doi:10.1371/journal.pntd.0000616
Gessner A, Moskophidis D, Lehmann-Grube F (1989) Enumeration of single IFN-gamma-producing cells in mice during viral and bacterial infection. J Immunol 142(4):1293–1298
Gibbert K, Schlaak JF, Yang D, Dittmer U (2013) IFN-alpha subtypes: distinct biological activities in anti-viral therapy. Br J Pharmacol 168(5):1048–1058. doi:10.1111/bph.12010
Godot V, Harraga S, Podoprigora G, Liance M, Bardonnet K, Vuitton DA (2003) IFN alpha-2a protects mice against a helminth infection of the liver and modulates immune responses. Gastroenterology 124(5):1441–1450
Harraga S et al (1999) Clinical efficacy of and switch from T helper 2 to T helper 1 cytokine profile after interferon alpha2a monotherapy for human echinococcosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 29(1):205–206. doi:10.1086/520157
Jamshidi M, Mohraz M, Zangeneh M, Jamshidi A (2008) The effect of combination therapy with albendazole and praziquantel on hydatid cyst treatment. Parasitol Res 103(1):195–199. doi:10.1007/s00436-008-0954-z
Kern P (2006) Medical treatment of echinococcosis under the guidance of good clinical practice (GCP/ICH). Parasitol Int 55(Suppl):S273–S282. doi:10.1016/j.parint.2005.11.040
Laura C, Celina E, Sergio SB, Guillermo D, Carlos L, Luis A (2015) Combined flubendazole-nitazoxanide treatment of cystic echinococcosis: pharmacokinetic and efficacy assessment in mice. Acta Trop 148:89–96. doi:10.1016/j.actatropica.2015.04.019
Maggiore M, Pensel PE, Denegri G, Elissondo MC (2015) Chemoprophylactic and therapeutic efficacy of thymol in murine cystic echinococcosis. Parasitol Int 64(5):435–440. doi:10.1016/j.parint.2015.06.005
Mahmoudvand H et al (2014) Scolicidal effects of biogenic selenium nanoparticles against protoscolices of hydatid cysts. Int J Surg 12(5):399–403. doi:10.1016/j.ijsu.2014.03.017
Menezes da Silva A (2003) Hydatid cyst of the liver-criteria for the selection of appropriate treatment. Acta Trop 85(2):237–242
Moazeni M, Larki S, Oryan A, Saharkhiz MJ (2014) Preventive and therapeutic effects of Zataria multiflora methanolic extract on hydatid cyst: an in vivo study. Vet Parasitol 205(1–2):107–112. doi:10.1016/j.vetpar.2014.07.006
Moro P, Schantz PM (2009) Echinococcosis: a review. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 13(2):125–133. doi:10.1016/j.ijid.2008.03.037
Pensel PE, Albani C, Gamboa GU, Benoit JP, Elissondo MC (2014) In vitro effect of 5-fluorouracil and paclitaxel on Echinococcus granulosus larvae and cells. Acta Trop 140:1–9. doi:10.1016/j.actatropica.2014.07.013
Pensel PE et al (2015) Cystic echinococcosis therapy: albendazole-loaded lipid nanocapsules enhance the oral bioavailability and efficacy in experimentally infected mice. Acta Trop 152:185–194. doi:10.1016/j.actatropica.2015.09.016
Rigano R, Profumo E, Di Felice G, Ortona E, Teggi A, Siracusano A (1995) In vitro production of cytokines by peripheral blood mononuclear cells from hydatid patients. Clin Exp Immunol 99(3):433–439
Rizza P, Capone I, Moretti F, Proietti E, Belardelli F (2011) IFN-alpha as a vaccine adjuvant: recent insights into the mechanisms and perspectives for its clinical use. Expert review of vaccines 10(4):487–498. doi:10.1586/erv.11.9
Romagnani S (1995) Biology of human TH1 and TH2 cells. J Clin Immunol 15(3):121–129
Spicher M et al (2008) In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives. Antimicrob Agents Chemother 52(9):3447–3450. doi:10.1128/AAC.00553-08
Uze G, Tavernier J (2015) High efficiency targeting of IFN-alpha activity: possible applications in fighting tumours and infections. Cytokine Growth Factor Rev 26(2):179–182. doi:10.1016/j.cytogfr.2014.10.006
Zhang W, Wen H, Li J, Lin R, McManus DP (2012) Immunology and immunodiagnosis of cystic echinococcosis: an update. Clinical & developmental immunology 2012:101895. doi:10.1155/2012/101895
Acknowledgements
This work was supported by the International S&T Cooperation Program of China (ISTCP) (Grant No. 2011DFA32740).
Author contributions
SZ, BL, and HW designed and wrote the paper. SZ, BL, HW, YZ, LS, and XZ performed the research.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Zhang, S., Zhou, Y., Su, L. et al. In vivo evaluation of the efficacy of combined albedazole-IFN-α treatment for cystic echinococcosis in mice. Parasitol Res 116, 735–742 (2017). https://doi.org/10.1007/s00436-016-5339-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-016-5339-0